{
    "query": "Assess structural feasibility of Nanostructured Lipid Carrier (NLC) Upadacitinib",
    "molecule_name": "Upadacitinib",
    "formulation_type": "Nanostructured Lipid Carrier (NLC)",
    "target_condition": "Atopic Dermatitis",
    "side_effect_mitigation": "Acneiform Eruption",
    "context": {
        "source": "EXP-03 Final Pivot from SLN Failure",
        "evidence": [
            "SLN failed due to drug expulsion (SR9=0.27).",
            "NLCs incorporate a liquid lipid (e.g., Oleic Acid) into the solid core.",
            "This creates a chaotic, imperfect crystal lattice with more space for drug accommodation.",
            "Expected to prevent crystallization and significantly improve long-term stability and drug loading."
        ],
        "pivot_rationale": "Correcting the perfect crystallinity of SLN by adding liquid lipid perturbation."
    }
}